IO Biotech Inc. (NASDAQ: IOBT) Stock Information | RedChip
Image

ASK REDCHAT® ANYTHING ABOUT IO BIOTECH INC.

IO Biotech Inc. (NASDAQ: IOBT)
Listen to this Section


$0.91
-0.0380 ( -2.09% ) 12.1K

IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.

Market Data


Open $0.91
Previous Close $0.95
Volume 12.1K
Market Cap $61.37M
Day Range $0.89 - $0.94
52 Week Range $0.66 - $1.89
Shares Outstanding 65.88M
Change % -2.09%
Net Change ▼ -0.0380
Insider Ownership 0.01%
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology: Pharmaceutical Preparations
IPO Year 2021
Country Denmark
Under Writer Morgan Stanley, Jefferies, TD Cowen, Kempen, more

Insider Ownership Transactions

Total Amount Purchased: -13,512,164.00

Date Type Amount Purchased Purchaser
2024-12-26 Buy 31350.00 Ahmad Qasim Iftikhar
2024-12-23 Buy 10250.00 Sullivan Amy
2024-12-23 Buy 12000.00 Smith Devin Whittemore
2024-12-23 Buy 12500.00 Zocca Mai-Britt
2024-07-26 Sale -51522.00 Novo Holdings A/S
2024-06-07 Sale -45642.00 Glaub Kathleen Sereda
2024-06-07 Sale -45642.00 Elling Christian E
2024-06-07 Sale -45642.00 Collins Helen Louise
2024-06-07 Sale -45642.00 Hunter Heidi
2024-06-07 Sale -45642.00 Smith David V

Institutional Ownership

Total Market Value $ 0.00

Symbol Issuer Name Market Value ↓ Share Quantity
No records found.

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 15 May 14, 2024
144 Insider transactions 1 May 10, 2024
8-k 8K-related 13 Apr 26, 2024
def Proxies and info statements 5 Apr 24, 2024
defa14a Other 3 Apr 24, 2024
ars Annual reports 1 Apr 24, 2024
10-k/a Quarterly Reports 17 Mar 22, 2024
4 Insider transactions 1 Mar 18, 2024
4 Insider transactions 1 Mar 18, 2024
4 Insider transactions 1 Mar 18, 2024

Latest News


× Before browsing our site, please accept our cookies policy